Unlicensed Botox in Portugal: How to Avoid Permanent Facial Damage Before Booking

Beauty treatments gone wrong aren't just aesthetic embarrassments—they're medical emergencies. On Tuesday, four Portuguese agencies announced a sweeping enforcement campaign targeting a crisis of unlicensed injectable procedures, with 1,000 documented complaints in nine years alone and a troubling uptick in tissue necrosis, nerve damage, and permanent facial paralysis cases traced to unqualified practitioners working out of salons and makeshift clinics.

Key Takeaways

• 19 clinics suspended in three years; enforcement orders jumped 300% year-over-year in 2025, with the ERS issuing four prohibition orders compared to one in 2024.

• Botox and filler require physician licenses—no exceptions, no shortcuts. Beauticians performing these procedures face criminal charges for usurpation of medical practice.

• Vascular occlusion can cause serious complications—including tissue damage when fillers enter blood vessels near the eyes.

• Verify credentials instantly via the ERS database (ers.pt) before any facial procedure; ask to see the practitioner's professional ID card.

The Numbers Behind the Crisis

Portugal's health and consumer protection agencies have been documenting a surge of harm that finally prompted this coordinated public alert. The Portugal Health Regulatory Authority (ERS) received nearly 450 complaints and filed 82 inspection orders last year alone—nearly double the activity of prior years. The Authority for Food and Economic Security (ASAE) logged 521 separate denunciations since 2019, with five already filed in the opening months of 2026. Together, they processed roughly 1,000 allegations across nine years, yet the trend lines reveal acceleration: complaints and enforcement actions have doubled in the past 24 months.

This enforcement wave is driven by documented injury, not bureaucratic anxiety. Between 2021 and 2025, the ERS fielded 438 distinct requests for guidance on professional qualifications and legal clinic requirements—a sign that confusion about what's permitted is widespread among consumers and practitioners alike. The agencies conducted 204 site inspections in that same period, with 49 of those as joint multi-agency raids involving the ERS, ASAE, and Infarmed (the national medicines authority).

The result: 19 establishments shut down over the past three years. In 2025, the ERS issued four formal prohibition orders against clinics previously flagged during inspections—a significant increase compared to one such order in 2024. Several outlets chose to voluntarily cease operations after regulatory contact, acknowledging they were operating beyond their legal scope. Others simply disappeared or relocated.

Why Demand for Injectable Procedures Is Growing

Portugal's spike in aesthetic procedure demand reflects broader consumer interest in minimally invasive facial work. The ERS notes that demand for these procedures has grown substantially in recent years, driven by multiple factors including social media visibility, influencer documentation of cosmetic treatments, and changing attitudes toward preventive aesthetic procedures among younger demographics.

The shift in consumer expectations has created market pressure: young adults increasingly seek treatments their parents' generation viewed as exceptional, and affordable access—or perceived affordability—influences decision-making. This demand surge creates opportunity for both legitimate practitioners and unlicensed operators, as consumers may prioritize convenience and cost over credential verification.

Between 2020 and 2021, global aesthetic procedure volume expanded significantly, with non-surgical injectables accounting for substantial growth. Portugal matched this trajectory.

What Happens When Botox Meets Untrained Hands

The distinction between a cosmetic concern and a medical emergency hinges entirely on who holds the needle. Botulinum toxin and hyaluronic acid fillers are classified as prescription medicines in Portugal, not cosmetics. They require anatomical precision, emergency-response training, and complication-management expertise that beauticians, aestheticians, and self-taught practitioners simply do not possess.

The damage catalog from unlicensed injections includes:

Vascular Complications: When filler enters or compresses blood vessels—a risk heightened by improper depth of injection—tissue downstream from that blockage can suffer oxygen deprivation. Necrosis (tissue death) in the nose, lips, or cheeks becomes visible within hours, creating permanent scarring and disfigurement. Complications affecting high-risk zones near the eyes present particular concern and have been documented in serious injury reports.

Neurological Damage: Botox positioned incorrectly near facial nerves causes ptosis (drooping eyelids), dysphagia (difficulty swallowing), or dysarthria (slurred speech). Patients have reported weeks or months of speech difficulty after botox applied by unlicensed practitioners. Nerve damage from filler injection can trigger chronic facial pain or numbness.

Systemic Infection: Non-sterile needles or contaminated filler products introduce bacteria directly into facial tissue, where they proliferate rapidly. Minor infections can progress to abscesses; untreated infections can develop into serious complications requiring antibiotic treatment and medical intervention.

Counterfeit or Improperly Stored Products: Fake or improperly stored botulinum toxin poses a distinct risk. The toxin degrades with improper storage, concentrating dangerously or becoming unstable. Licensed practitioners maintain strict storage and handling protocols; unlicensed operators often do not.

Granulomas and Chronic Inflammation: Foreign material seated incorrectly can trigger a chronic immune response, forming permanent nodules or inflammatory cysts that require surgical removal, additional procedures, and medical management.

The Unlicensed Market: Where Procedures Happen

Who is performing these injections? The ASAE data identifies a motley assortment of venues: beauty salons, barbershops, nail parlors, "wellness centers," and unlicensed home-based operations. Some practitioners claim to hold certifications from online schools or weekend courses offering "aesthetic injection training." None of this substitutes for medical licensure.

In Portugal, only physicians and dentists registered with their respective professional orders may legally administer botox or hyaluronic acid. Period. A cosmetologist, esthetician, or nurse cannot perform these procedures, regardless of training. The law is explicit because the procedures are explicitly medical—they carry real risk of serious harm, and only practitioners with years of formal medical education, anatomy training, and supervised clinical practice have the knowledge to manage emergencies.

Yet enforcement has been haphazard until now. The campaign reflects a recognition that information asymmetry—consumers unaware of the risks or the licensing requirements—enables the unlicensed market to thrive. A cheap botox procedure at a salon seems like a bargain until serious complications appear.

What Residents Must Verify Before Booking

The Portugal Health Regulatory Authority has published a consumer checklist. Before stepping into any aesthetic clinic for injectables, follow this protocol:

At the clinic (in-person checks):

• Confirm an ERS registration certificate is prominently displayed, along with a valid health and safety license specifying which procedures are authorized.

• Identify the clinical director's name on the license; this person bears legal responsibility for all care delivered on-site.

• Confirm the presence of a complaints book (livro de reclamações), a mandatory record where dissatisfied clients lodge formal grievances. Any clinic lacking one is operating illegally.

• Observe sanitation protocols: sterile field setup, single-use needles opened in front of you, hand hygiene, glove changes between clients.

About the practitioner:

• Request to see the practitioner's professional identification card (cédula profissional), issued by the Medical Order (Ordem dos Médicos) or Dental Order (Ordem dos Médicos Dentistas).

• Verify active registration via the respective order's public database—both orders publish searchable registries online.

• Ask directly: "Are you a physician or dentist?" If the answer is equivocal or vague, leave.

Pre-procedure conversation:

• Discuss your medical history: anticoagulants, allergies, previous adverse reactions, pregnancy status, autoimmune conditions.

• Request a written consent form that explains risks, expected outcomes, and post-care instructions. Any clinic refusing written consent is a red flag.

• Ask about the specific product being used: brand name, batch number, expiration date. Legitimate clinics track this for traceability and adverse-event reporting.

Red flags—do not proceed if:

• The practitioner refuses to show professional credentials.

• Prices are dramatically below market rate (typically €300–€600 for botox; €400–€800 for filler), signaling either counterfeit product or unqualified provider.

• Heavy social media advertising with no visible regulatory oversight.

• The clinic offers "training" or "certification" for injectables in weekend courses.

• No ERS registration when you check the database at https://ers.pt/pt/prestadores/servicos/pesquisa-de-prestadores/.

How the ERS Database Works

The ERS registry is publicly searchable and updated in real time. Enter the clinic's name or practitioner's name, and the system returns:

• Legal status (active, suspended, or closed).

• All authorized procedures by type.

• Staff roster with individual professional credentials.

• Any active sanctions or prohibition orders.

This tool—free and accessible from a smartphone—obliterates the excuse "I didn't know." Information asymmetry, the primary enabler of unlicensed practice, dissolves when a consumer spends 60 seconds verifying credentials online before an appointment.

Enforcement Machinery and Recent Escalation

The four agencies—ERS, Infarmed, ASAE, and the Directorate-General for Consumer Affairs—have formalized joint inspection protocols. Between 2023 and 2025, they conducted 49 coordinated raids targeting high-risk establishments. This model pools regulatory expertise: health inspectors check medical practice standards; food safety experts verify product sourcing and storage; consumer protection specialists examine advertising and contract terms.

The escalation in enforcement orders reflects both increased vigilance and worsening violations. In 2024, the ERS issued one formal prohibition order. In 2025, that number increased to four—a significant rise in enforcement action. Several establishments under investigation suspended operations voluntarily after regulatory contact, essentially admitting they were operating illegally. Investigators note that repeat offenders are resurfacing, sometimes under new business names or in adjacent cities, suggesting that closure orders are forcing practitioners to relocate rather than rehabilitate.

The ERS emphasizes that suspension orders include mandatory corrective-action plans. Clinics can reopen only after demonstrating compliance with regulations—hiring qualified staff, obtaining proper licensing, and submitting to follow-up inspections. Voluntary suspension, however, sometimes signals avoidance: a clinic closes to evade formal penalties but may reopen elsewhere without genuinely reforming practices.

Impact on Residents: Safety, Transparency, and Consumer Choice

For anyone living in Portugal considering facial injectables, the practical implications are straightforward:

Transparency is now enforceable. Clinics must display credentials, and residents can verify them independently before booking. The information asymmetry that once favored unlicensed operators has been largely eliminated by digital tools.

Legitimate practitioners benefit from crackdowns. As unlicensed competitors face closure, the market reputation of licensed, compliant clinics improves. Legitimate practitioners no longer compete on price with cut-rate unlicensed operations; the competitive landscape shifts toward quality and safety.

Patients bear responsibility for verification. The ERS campaign does not discourage aesthetic procedures—it empowers choice. Residents who ignore red flags or skip credential verification assume the risk of complications. The law and regulators provide the tools; consumers must use them.

Medical tourism carries identical risks. Some Portuguese residents travel to Spain, France, or across borders for cheaper procedures, assuming that "overseas" automatically means "safer." It does not. Practitioners in other countries may face identical enforcement gaps, and legal recourse across borders is complex. The campaign's message applies universally: verify credentials wherever you seek treatment.

Younger demographics require targeted messaging. The ERS and its partners are distributing content via Instagram, TikTok, and YouTube, not just traditional media. The campaign includes testimonials from patients harmed by unlicensed practitioners, deliberately contrasting the aspirational aesthetic with the reality of serious complications. This counternarrative aims to reach the exact demographic—20-somethings most vulnerable to low-cost, high-risk procedures.

The Regulatory Rationale: Safety as Non-Negotiable

The four agencies are framing this not as anti-beauty paternalism but as harm reduction grounded in concrete injury data. Infections, tissue damage, and other complications are not hypothetical risks—they are documented outcomes from unlicensed practice. The 1,000 complaints over nine years, the 19 clinic closures, and the 438 qualification inquiries to the ERS represent a consistent signal: consumers are encountering injury and seeking recourse.

The campaign's central message is unambiguous: aesthetic medicine is still medicine. The absence of a scalpel does not eliminate risk. Vascular anatomy, pharmacology, aseptic technique, and emergency-response capability require years of formal training. These credentials cannot be bypassed or compressed into weekend certifications.

For residents of Portugal, the practical takeaway is equally clear: the tools to verify safety are now publicly accessible, and ignorance of a practitioner's qualifications—or willful disregard of red flags—is no longer a defense after injury occurs. The choice to use these tools, and the responsibility for outcomes when they are ignored, rests with the consumer.